These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8914623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital.
    Grasl-Kraupp B, Waldhör T, Huber W, Schulte-Hermann R.
    Carcinogenesis; 1993 Nov; 14(11):2407-12. PubMed ID: 8242872
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
    Tomaszewski KE, Agarwal DK, Melnick RL.
    Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
    Tomaszewski KE, Heindel SW, Jenkins WL, Melnick RL.
    Toxicology; 1990 Dec 17; 65(1-2):49-60. PubMed ID: 2274969
    [Abstract] [Full Text] [Related]

  • 8. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats.
    Hayashi F, Tamura H, Yamada J, Kasai H, Suga T.
    Carcinogenesis; 1994 Oct 17; 15(10):2215-9. PubMed ID: 7955056
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
    Furukawa K, Numoto S, Furuya K, Furukawa NT, Williams GM.
    Cancer Res; 1985 Oct 17; 45(10):5011-9. PubMed ID: 2862989
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin.
    Abdellatif AG, Préat V, Vamecq J, Nilsson R, Roberfroid M.
    Carcinogenesis; 1990 Nov 17; 11(11):1899-902. PubMed ID: 2225320
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of peroxisome proliferator carcinogens on unscheduled DNA synthesis in rat hepatocytes determined by autoradiography.
    Cattley RC, Richardson KK, Smith-Oliver T, Popp JA, Butterworth BE.
    Cancer Lett; 1986 Dec 17; 33(3):269-77. PubMed ID: 3802057
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferation and resistance to hydrogen peroxide in rat hepatocytes: is development of resistance an adaptation to cytotoxicity?
    Garberg P, Stenius U, Nilsson K, Högberg J.
    Carcinogenesis; 1992 Oct 17; 13(10):1751-8. PubMed ID: 1423834
    [Abstract] [Full Text] [Related]

  • 15. Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats.
    Lake BG, Gray TJ, Körösi SA, Walters DG.
    Toxicol Lett; 1989 Feb 17; 45(2-3):221-9. PubMed ID: 2919403
    [Abstract] [Full Text] [Related]

  • 16. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
    Conway JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, Popp JA.
    Carcinogenesis; 1989 Mar 17; 10(3):513-9. PubMed ID: 2924396
    [Abstract] [Full Text] [Related]

  • 17. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS, Cattley RC, Conway JG, Popp JA.
    Cancer Res; 1988 Dec 01; 48(23):6739-44. PubMed ID: 3180084
    [Abstract] [Full Text] [Related]

  • 18. The effects of peroxisome proliferators on protein abundances in mouse liver.
    Anderson NL, Esquer-Blasco R, Richardson F, Foxworthy P, Eacho P.
    Toxicol Appl Pharmacol; 1996 Mar 01; 137(1):75-89. PubMed ID: 8607144
    [Abstract] [Full Text] [Related]

  • 19. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
    Melnick RL.
    Environ Health Perspect; 2001 May 01; 109(5):437-42. PubMed ID: 11401753
    [Abstract] [Full Text] [Related]

  • 20. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression.
    Hasmall SC, James NH, Macdonald N, Soames AR, Roberts RA.
    Arch Toxicol; 2000 Apr 01; 74(2):85-91. PubMed ID: 10839475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.